A comparison of the effects of tirilazad on subarachnoid hemorrhage-induced blood-brain barrier permeability in male and female rats

Journal of Stroke and Cerebrovascular Diseases

Volumn 6, Issue 6, 1997, Pages 389-393

  Smith, Sarah L ^a   Larson, Philip G ^a   Hall, Edward D ^a  

^a PFIZER INC   (United States)

Author keywords

Blood brain barrier permeability; Gender differences; Subarachnoid hemorrhage; Tirilazad

Indexed keywords

EID: 0342379171     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1052-3057(97)80039-0     Document Type: Article

References (31)

1. Hall E.D. Inhibition of lipid peroxidation in central nervous system trauma and ischemia [suppl]. J Neuro Sci 134 (1995) 79-83
2. Hall E.D. Efficacy and mechanism of action of the cytoprotective lipid peroxidation inhibitor tirilazad mesylate in subarachnoid haemorrhage. Eur J Anaesth 13 (1996) 279-289
3. Hall E.D., McCall J.M., and Means E.D. Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia and subarachnoid hemorrhage. Adv Pharmacol 28 (1994) 221-268
4. Kassell N.F., Haley E.C., Apperson-Hansen C., and Alves W.M. Randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand. J Neurosurg 84 (1996) 221-228
5. Fleishaker J.C., Hulst L.K., and Peters G.R. Lack of pharmacokinetic interaction between cimetidine and tirilazad mesylate. Pharm Res 11 (1994) 341-344
6. Fleishaker J.C., Hulst-Pearson L.K., and Peters G.R. Effect of gender and menopausal status on the pharmacokinetics of tirilazad mesylate in healthy subjects. Am J Ther 2 (1995) 553-560
7. Hulst L.K., Fleishaker J.C., Peters G.R., Harry J.D., Wright D.M., and Ward P. Effect of age and gender on tirilazad pharmacokinetics in humans. Clin Pharmacol Ther 55 (1994) 378-384
8. Smith S.L., Scherch H.M., and Hall E.D. Protective effects of tirilazad mesylate and metabolite U-89678 against blood-brain barrier damage after subarachnoid hemorrhage and lipid peroxidative neuronal injury. J Neurosurg 84 (1996) 229-233
9. Zuccarello M., and Anderson D.K. Protective effect of a 21-aminosteroid on the blood-brain barrier following subarachnoid hemorrhage in rats. Stroke 20 (1989) 367-371
10. Doczi T., Joo F., Adam G., Bozoky B., and Szerdahelyi P. Blood-brain barrier damage during the acute stage of subarachnoid hemorrhage, as exemplified by a new animal model. Neurosurgery 18 (1986) 733-739
11. Germano A., d'Avella D., Ciccariello R., Hayes R.L., and Tomosello F. Blood-brain barrier permeability changes after experimental subarachnoid hemorrhage. Neurosurgery 30 (1992) 882-886
12. Asano T., Matsui T., and Takuwa Y. Lipid peroxidation, protein kinase C and cerebral vasospasm. Crit Rev Neurosurg 1 (1991) 361-379
13. Macdonald R.L., Weir B.K., Runzer T.D., and Grace M. Malonydialdehyde, glutathione peroxidase, and superoxide dismutase in cerebrospinal fluid during cerebral vasospasm in monkeys. Can J Neurol Sci 19 (1992) 326-332
14. Sano K., Asano T., Tanismima T., and Sasaki T. Lipid peroxidation as a cause of cerebral vasospasm. Neurol Res 2 (1980) 253-272
15. Jakobsen M. Role of initial brain ischemia in subarachnoid hemorrhage following aneurysm rupture [suppl 141]. Acta Neurol Scand 86 (1992) 1-33
16. Umansky F., Kaspi T., and Shalit M. Regional cerebral blood flow in the acute stage of experimentally induced subarachnoid hemorrhage. J Neurosurg 58 (1983) 210-216
17. Nagagomi T., Kassell N.F., Sasaki T., Fujiwara S., Lehman R.M., Johishita H., et al. Effect of subarachnoid hemorrhage on endothelium-dependent vasodilation. J Neurosurg 66 (1987) 915-923
18. Chyatte D., and Sundt T.M. Cerebral vasospasm after subarachnoid hemorrhage. Mayo Clin Proc 59 (1984) 498-505
19. Kassell N.F., Sasaki T., Colohan A., and Nazar G. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 16 (1985) 562-572
20. Braughler J.M., Hall E.D., Jacobsen E.J., McCall J.M., and Means E.D. The 21-aminosteroids: potent inhibitors of lipid peroxidation for the treatment of central nervous system trauma. Drugs Future 14 (1989) 143-152
21. Audus K.L., Guillot F.L., and Braughler J.M. Evidence for 21-aminosteroid association with the hydrophobic domains of brain microvessel endothelial cells. Free Rad Biol Med 11 (1991) 361-371
22. Hinzmann J.S., McKenna R.L., Pierson T.S., Han F., Kezdy F.J., and Epps D.E. Interaction of antioxidants with depth-dependent fluorescence quenchers and energy transfer probes in lipid bilayers. Chem Phys Lipids 62 (1992) 123-138
23. Raub T.J., Barsuhn C.L., Williams L.R., Decker D.E., Sawada G.A., and Ho N.F.H. Application of a biophysical-kinetic model to understand the roles of protein binding and membrane partitioning on passive diffusion of highly lipophilic molecules across cellular barriers. J Drug Targeting 1 (1993) 269-286
24. Hall E.D., and Travis M.A. Effects of the non-glucocorticoid 21-aminosteroid U-74006F on acute cerebral hypoperfusion following experimental subarachnoid hemorrhage. Exp Neurol 102 (1988) 244-248
25. Steinke D.E., Weir B., Findlay J.M., Tanabe T., Grace M., and Kruschelnycky B.W. A trial of the 21-aminosteroid U-74006F in a primate model of chronic cerebral vasospasm. Neurosurgery 24 (1989) 179-186
26. Vollmer D.G., Kassell N.F., Hongo K., Ogwawa H., and Tsukahara T. Effect of the non-glucocorticoid 21-aminosteroid U-74006F on experimental cerebral vasospasm. Surg Neurol 31 (1989) 190-194
27. Zuccarello M., Marsch J.T., Schmitt G., Woodward J., and Anderson D.K. Effect of the 21-aminosteroid U-74006F on cerebral vasospasm following subarachnoid hemorrhage. J Neurosurg 71 (1989) 98-104
28. Matsui T., and Asano T. Effects of new 21-aminosteroid tirilazad mesylate (U74006F) on chronic cerebral vasospasm in a "two-hemorrhage" model of beagle dogs. Neurosurg 34 (1994) 1035-1039
29. Kanamaru K., Weir B., Simpson I., Witbeck T., and Grace M. Effect of 21-aminosteroid U-74006F on lipid peroxidation in subarachnoid clot. J Neurosurg 74 (1991) 454-459
30. Sasaki T., Kassell N.F., Yamashita M., Fujiwara S., and Zuccarello M. Barrier disruption in the major cerebral arteries following experimental subarachnoid hemorrhage. J Neurosurg 63 (1985) 433-440
31. Sasaki T., Kassell N.F., Zuccarello M., Nakagomi T., Fujiwara S., Colohan A., and Lehman M. Barrier disruption in the major cerebral arteries during the acute stage after experimental subarachnoid hemorrhage. Neurosurgery 19 (1986) 177-184